SKI Market

A+| A| A-|

Indian Indices

Sensex

75,527.95 1,695.40
( 2.30%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

66,063.56 1,846.29
(2.88%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.49 0.16
(0.17%)

EUR-INR

110.25 0.17
(0.15%)

GBP-INR

127.74 0.15
(0.12%)

JPY-INR

0.60 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

ERIS Lifesciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

540596

INE406M01024

230.6075957

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ERIS

76.54

19439.6

EPS(TTM)

Face Value()

Div & Yield %

18.33

0.51

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	1704.03	1528.28	1340.37	1215.73	1108.83	1020.23
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1704.03	1528.28	1340.37	1215.73	1108.83	1020.23
Other Income	35.51	34.83	17.26	28.99	10.00	14.73
Stock Adjustments	43.54	13.15	-8.50	-2.49	12.57	-17.47
Total Income	1783.08	1576.26	1349.13	1242.23	1131.40	1017.49
EXPENDITURE :
Raw Materials	542.79	293.31	227.88	197.16	211.08	146.88
Power & Fuel Cost	4.10	4.46	4.41	4.01	3.89	4.54
Employee Cost	361.92	331.67	252.52	220.11	207.02	191.73
Other Manufacturing Expenses	22.35	16.80	11.50	7.47	7.16	10.62
Selling & Administrative Expenses	223.80	319.27	242.67	215.51	181.66	219.34
Miscellaneous Expenses	106.06	122.10	87.78	84.93	93.13	73.93
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1261.02	1087.61	826.75	729.18	703.93	647.04
Operating Profit	522.06	488.65	522.38	513.04	427.47	370.44
Interest	220.24	57.42	20.81	3.05	0.94	1.97
Gross Profit	301.82	431.23	501.57	509.99	426.53	368.47
Depreciation	181.77	102.39	64.66	51.46	37.64	44.88
Profit Before Tax	120.05	328.84	436.91	458.53	388.89	323.59
Tax	21.98	57.64	76.50	80.17	70.18	57.49
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	20.68	-28.52	-37.59	-38.83	-31.90	-25.17
Reported Net Profit	77.39	299.72	398.01	417.19	350.61	291.27
Extraordinary Items	1.35	2.79	5.17	-1.72	2.33	4.49
Adjusted Net Profit	76.04	296.93	392.84	418.91	348.28	286.78
Adjustment below Net Profit	-2.84	-2.76	-0.15	-1.01	-1.28	-100.21
P & L Balance brought forward	2487.17	2190.21	1892.28	1557.74	1283.09	1139.01
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	100.06	0.00	99.93	81.65	74.68	46.98
P & L Balance carried down	2461.66	2487.17	2190.21	1892.28	1557.74	1283.09
Dividend	0.00	0.00	99.93	81.65	74.68	38.97
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	735.00	0.00	735.00	601.00	550.00	287.00
Dividend Per Share(Rs)	7.35	0.00	7.35	6.01	5.50	2.87
Earnings Per Share-Unit Curr	5.68	22.04	29.27	30.69	25.82	21.45
Earnings Per Share(Adj)-Unit Curr	5.68	22.04	29.27	30.69	25.82	21.45
Book Value-Unit Curr	184.65	185.59	163.39	141.11	116.03	95.72
Book Value(Adj)-Unit Curr	184.65	185.59	163.39	141.11	116.03	95.72

75,527.95 1,695.40 ( 2.30%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

66,063.56 1,846.29 (2.88%)

10,460.24 156.36 (1.52%)

95.49 0.16 (0.17%)

110.25 0.17 (0.15%)

127.74 0.15 (0.12%)

0.60 0.00 (0.21%)